Introduction:
Hepatocellular cancer (HCC) is the sixth most common cancer worldwide and the third most common cause of cancer mortality. (KADALAYIL et al, 2013). Unfortunately, most patients have unresectable disease and liver transplantation is a curative and lifesaving treatment for these patients (SAN MIGUEL et al. , 2015).
Not all patients with HCC meet the eligibility criteria for liver transplantation. To reduce the tumor burden, downstaging through chemoembolization is used. Patients with HCC greater than 7 cm generally do not respond very well to chemoembolization to reduce tumor size and generally this “downstaging” is not performed (KADALAYIL et al,2013).
In the reported case, we have a patient with a HCC measuring 9.1 cm, who underwent chemoembolization to reduce staging, which was successful and thus reached the eligibility criteria for liver transplantation.